Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine

BACKGROUND: Combinations of hydroxychloroquine (HCQ) and azithromycin have been promoted as treatments for COVID-19 based on small, uncontrolled clinical trials that have not assessed potential risks. Risks of treatment include QT segment prolongation, Torsades de Pointes (TdP), and death. This comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarayani, Amir, Cicali, Brian, Henriksen, Carl H., Brown, Joshua D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166303/
https://www.ncbi.nlm.nih.gov/pubmed/32327397
http://dx.doi.org/10.1016/j.sapharm.2020.04.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166303/
https://www.ncbi.nlm.nih.gov/pubmed/32327397
http://dx.doi.org/10.1016/j.sapharm.2020.04.016

Ejemplares similares